Pharmacokinetics of hirudinNOWAK, G.Seminars in thrombosis and hemostasis. 1991, Vol 17, Num 2, pp 145-149, issn 0094-6176Article

HirudinFISCHER, Karl-Georg; SUTOR, Anton H.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 5, issn 0094-6176Serial Issue

Evaluation of an automated chromogenic substrate assay for the rapid determination of hirudin in plasmaHAFNER, G; FICKENSCHER, K; FRIESEN, H.-J et al.Thrombosis research. 1995, Vol 77, Num 2, pp 165-173, issn 0049-3848Article

Biological relevance of anti-recombinant hirudin antibodies: Results from in vitro and in vivo studiesLIEBE, Volker; BRÜCKMANN, Martina; FISCHER, Karl-Georg et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 5, pp 483-489, issn 0094-6176, 7 p.Article

Current developments in antithrombotic therapy: The role of antithrombin agentsBREDDIN, H. K.Pathophysiology of haemostasis and thrombosis (Print). 2002, Vol 32, pp 1-8, issn 1424-8832, 8 p., SUP3Conference Paper

Thrombopénies induites par l'héparine (TIH) de type II: apport d'une nouvelle hirudine recombinante = Type II heparin-induced thrombocytopeniaLa Presse médicale (1983). 1998, Vol 27, issn 0755-4982, 32 p., SUP2Conference Proceedings

Actualités en thérapeutique antithrombotique : de la sangsue à l'hirudine recombinante = news in antithrombotic therapy: from leech to recombinant hirudinBIRON-ANDREANI, C.Angéiologie (Paris). 1999, Vol 51, Num 2, pp 26-30, issn 0003-3049Article

Coexpression of BiP increased antithrombotic hirudin production in recombinant Saccharomyces cerevisiaeKIM, Myoung-Dong; HAN, Ki-Cheol; KANG, Hyun-Ah et al.Journal of biotechnology. 2003, Vol 101, Num 1, pp 81-87, issn 0168-1656, 7 p.Article

pharmacokinetics and anticoagulant effect of hirudin in manMARKWARDT, F; NOWAK, G; STURZEBECHER, J et al.Thrombosis and haemostasis. 1984, Vol 52, Num 2, pp 160-163, issn 0340-6245Article

Hirudin as alternative anticoagulant: A historical reviewMARKWARDT, Fritz.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 5, pp 405-413, issn 0094-6176, 9 p.Article

Hirudin in acute coronary syndromesVAN DE LOO, Andreas; BODE, Christoph.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 5, pp 459-465, issn 0094-6176, 7 p.Article

NERVE CORD SHORTENING INDUCED BY ACTIVATION OF THE FAST CONDUCTING SYSTEM IN THE LEECHMAGNI F; PELLEGRINO M.1975; BRAIN RES.; NETHERL.; DA. 1975; VOL. 90; NO 1; PP. 169-174; BIBL. 13REFArticle

Thromboses expérimentales: rôle de la thrombine, et inhibition par l'hirudine et d'autres antithrombotiques = Experimental thrombosis: thrombin function and inhibitory by hirudin and other antithromboticsDe Vaulx-Freund, Monique; Cazenave, Jean-Pierre.1992, 224 p.Thesis

Rotational thrombelastometry for the bedside monitoring of recombinant hirudinSUCKER, C; ZOTZ, R. B; GÖRLINGER, K et al.Acta anaesthesiologica scandinavica. 2008, Vol 52, Num 3, pp 358-362, issn 0001-5172, 5 p.Article

Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopeniaGREINACHER, A; LUBENOW, N; EICHLER, P et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 17, pp 2062-2065, issn 0009-7322, 4 p.Article

A functional clotting assay to monitor the hirudin dosageZAKIR, Ramzan M; HOFFMAN, William; BHATT, Biren A et al.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 2, pp 119-123, issn 0957-5235, 5 p.Article

Measurement of maximum thrombin generation capacity in blood and plasma using the thrombin generation assay (THROGA)NOWAK, Götz; LANGE, Ute; WIESENBURG, Annett et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 508-514, issn 0094-6176, 7 p.Conference Paper

The ecarin clotting time, a universal method to quantify direct thrombin inhibitorsNOWAK, Götz.Pathophysiology of haemostasis and thrombosis (Print). 2003, Vol 33, Num 4, pp 173-183, issn 1424-8832, 11 p.Article

Pharmacology of recombinant hirudinNOWAK, Götz.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 5, pp 415-423, issn 0094-6176, 9 p.Article

Anticoagulant activity of synthetic hirudin peptidesMARAGANORE, J. M; CHAO, B; JOSEPH, M. L et al.The Journal of biological chemistry (Print). 1989, Vol 264, Num 15, pp 8692-8698, issn 0021-9258Article

Antithrombogenic Modification of Small-Diameter Microfibrous Vascular GraftsHASHI, Craig K; DERUGIN, Nikita; JANAIRO, Randall Raphael R et al.Arteriosclerosis, thrombosis, and vascular biology. 2010, Vol 30, Num 8, pp 1621-1627, issn 1079-5642, 7 p.Article

Effect of Argatroban versus Recombinant Hirudin on Tissue-Factor-Mediated Thrombin Generation : An in Vitro StudySAMAMA, Meyer Michel; LE FLEM, Léna; GUINET, Céline et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 87-90, issn 0094-6176, 4 p., SUP1Article

Efficient targeted anticoagulant with active RGD motifQUN BI; XUE ZHOU; XIAODONG CEN et al.Thrombosis research. 2007, Vol 120, Num 4, pp 541-547, issn 0049-3848, 7 p.Article

Successful treatment of mesenterial venous thrombosis with recombinant hirudin- : a report of five casesPUURUNEN, Marja; LASSILA, Riitta.Thrombosis research. 2006, Vol 118, Num 2, pp 241-245, issn 0049-3848, 5 p.Article

Modified plasma-based ecarin clotting time assay for monitoring of recombinant hirudin during cardiac surgeryCHOI, Tak-Shun; KHAN, Adil I; GREILICH, Philip E et al.American journal of clinical pathology. 2006, Vol 125, Num 2, pp 290-295, issn 0002-9173, 6 p.Article